Margareth Ndomondo-Sigonda1,2, Jacqueline Miot3, Shan Naidoo4, Nelson E Masota5,6, Brian Ng'andu7, Nancy Ngum7, Eliangiringa Kaale6. 1. Pharmacology Division, Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. 766425@students.wits.ac.za. 2. African Union Development Agency -New Partnership for Africa's Development (AUDA-NEPAD), Midrand, South Africa. 766425@students.wits.ac.za. 3. Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. 4. Public Health Medicine Department, School of Public Health, University of Witwatersrand, Johannesburg, South Africa. 5. Institute for Pharmacy and Food Chemistry, University of Wuerzburg, Wuerzburg, Germany. 6. School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. 7. African Union Development Agency -New Partnership for Africa's Development (AUDA-NEPAD), Midrand, South Africa.
Abstract
BACKGROUND: Limited capacity to regulate medical products is associated with circulation of products which do not meet standards of quality, safety and efficacy with negative public health and economic outcomes. This study focused on assessing the effect of the East African Community (EAC) medicines regulatory harmonization initiative on the capacity of national medicines regulatory agencies, with a focus on registration and inspection systems. METHODS: An exploratory mixed-method design using both qualitative and quantitative data to access data from six national medicines regulatory authorities (NMRAs) and the EAC Secretariat. Data was collected using a combination of semi-structured interviews, questionnaires, and checklists for the period 2010/11-2015/16 with 2010/11 data serving as baseline. Heads of NMRAs, regulatory and monitoring and evaluation experts, and the EAC Secretariat Project Officer were enrolled in the study. A set of 14 indicators grouped into 6 categories were used to assess NMRAs performance. RESULTS: Policy and legal frameworks provide a foundation for effective regulation. Collaboration, harmonization, joint dossier reviews and inspections of manufacturing sites, reliance and cooperation are key factors for building trust and capacity among NMRAs. Five out of six of the EAC Partner States have comprehensive medicines laws with autonomous NMRAs. All the NMRAs have functional registration and good manufacturing practice inspection systems supported by regional harmonised guidelines for registration, inspection, quality management and information management systems with four NMRAs attaining ISO 9001:2015 certification. CONCLUSIONS: The EAC regulatory harmonization initiative has contributed to improved capacity to regulate medical products. The indicators generated from this research can be replicated for evaluation of similar initiatives across and beyond the African continent and contribute to public health policy.
BACKGROUND: Limited capacity to regulate medical products is associated with circulation of products which do not meet standards of quality, safety and efficacy with negative public health and economic outcomes. This study focused on assessing the effect of the East African Community (EAC) medicines regulatory harmonization initiative on the capacity of national medicines regulatory agencies, with a focus on registration and inspection systems. METHODS: An exploratory mixed-method design using both qualitative and quantitative data to access data from six national medicines regulatory authorities (NMRAs) and the EAC Secretariat. Data was collected using a combination of semi-structured interviews, questionnaires, and checklists for the period 2010/11-2015/16 with 2010/11 data serving as baseline. Heads of NMRAs, regulatory and monitoring and evaluation experts, and the EAC Secretariat Project Officer were enrolled in the study. A set of 14 indicators grouped into 6 categories were used to assess NMRAs performance. RESULTS: Policy and legal frameworks provide a foundation for effective regulation. Collaboration, harmonization, joint dossier reviews and inspections of manufacturing sites, reliance and cooperation are key factors for building trust and capacity among NMRAs. Five out of six of the EAC Partner States have comprehensive medicines laws with autonomous NMRAs. All the NMRAs have functional registration and good manufacturing practice inspection systems supported by regional harmonised guidelines for registration, inspection, quality management and information management systems with four NMRAs attaining ISO 9001:2015 certification. CONCLUSIONS: The EAC regulatory harmonization initiative has contributed to improved capacity to regulate medical products. The indicators generated from this research can be replicated for evaluation of similar initiatives across and beyond the African continent and contribute to public health policy.
Entities:
Keywords:
Africa regulatory harmonization; East African community; Efficiency; Governance; Medical products regulation; Registration; Regulatory capacity; Regulatory inspection
Authors: Mawien Arik; Emmanuel Bamenyekanye; Adam Fimbo; Joseph Kabatende; Agnes Sitta Kijo; Burhani Simai; Fred Siyoi; Samvel Azatyan; Aggrey Ambali; Emer Cooke; Jane H Mashingia; John Patrick Mwesigye; Margareth Ndomondo-Sigonda; Hiiti Sillo; Stanley Sonoiya; Paul Tanui; Mike Ward; Thomas Delano Journal: PLoS Med Date: 2020-08-12 Impact factor: 11.069
Authors: Jane H Mashingia; Vincent Ahonkhai; Noel Aineplan; Aggrey Ambali; Apollo Angole; Mawien Arik; Samvel Azatyan; Peter Baak; Emmanuel Bamenyekanye; Aimable Bizoza; Chimwemwe Chamdimba; Petra Doerr; Adam Fimbo; Alex Gisagara; Hidaya Hamad; Rachelle Harris; Dan Hartman; Joseph Kabatende; Charles Karangwa; Agnes Sitta Kijo; Murray Lumpkin; Shani Maboko; David Matle; Apollo Muhairwe; John Patrick Mwesigye; Bonaventure Nyabenda; Alexander Schulze; Andreas Seiter; Gordon Sematiko; Margareth Sigonda; Hiiti Sillo; Burhani Simai; Fred Siyoi; Stanley Sonoiya; Paul Tanui; Mike Ward; Felistas Yano; David Mukanga Journal: PLoS Med Date: 2020-08-12 Impact factor: 11.069
Authors: Vijay Kumar Chattu; Vishal B Dave; K Srikanth Reddy; Bawa Singh; Biniyam Sahiledengle; Demisu Zenbaba Heyi; Cornelius Nattey; Daniel Atlaw; Kioko Jackson; Ziad El-Khatib; Akram Ali Eltom Journal: Int J Environ Res Public Health Date: 2021-11-09 Impact factor: 3.390
Authors: George M Warimwe; Michael J Francis; Thomas A Bowden; Samuel M Thumbi; Bryan Charleston Journal: Nat Rev Immunol Date: 2021-06-17 Impact factor: 53.106